These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 33093014)

  • 1. ETV5 Regulates Hepatic Fatty Acid Metabolism Through PPAR Signaling Pathway.
    Mao Z; Feng M; Li Z; Zhou M; Xu L; Pan K; Wang S; Su W; Zhang W
    Diabetes; 2021 Jan; 70(1):214-226. PubMed ID: 33093014
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LB100 ameliorates nonalcoholic fatty liver disease
    Chen XY; Cai CZ; Yu ML; Feng ZM; Zhang YW; Liu PH; Zeng H; Yu CH
    World J Gastroenterol; 2019 Dec; 25(45):6607-6618. PubMed ID: 31832001
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Saturated Fatty Acid-Induced Impairment of Hepatic Lipid Metabolism Is Worsened by Prohibitin 1 Deficiency in Hepatocytes.
    Yanran W; Jung S; Ko KS
    J Med Food; 2022 Aug; 25(8):845-852. PubMed ID: 35980329
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bone morphogenetic protein 4 (BMP4) alleviates hepatic steatosis by increasing hepatic lipid turnover and inhibiting the mTORC1 signaling axis in hepatocytes.
    Peng Q; Chen B; Wang H; Zhu Y; Wu J; Luo Y; Zuo G; Luo J; Zhou L; Shi Q; Weng Y; Huang A; He TC; Fan J
    Aging (Albany NY); 2019 Dec; 11(23):11520-11540. PubMed ID: 31831718
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiotrophin-1 eliminates hepatic steatosis in obese mice by mechanisms involving AMPK activation.
    Castaño D; Larequi E; Belza I; Astudillo AM; Martínez-Ansó E; Balsinde J; Argemi J; Aragon T; Moreno-Aliaga MJ; Muntane J; Prieto J; Bustos M
    J Hepatol; 2014 May; 60(5):1017-25. PubMed ID: 24362075
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatic lipid accumulation: cause and consequence of dysregulated glucoregulatory hormones.
    Geisler CE; Renquist BJ
    J Endocrinol; 2017 Jul; 234(1):R1-R21. PubMed ID: 28428362
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FOXK1 promotes nonalcoholic fatty liver disease by mediating mTORC1-dependent inhibition of hepatic fatty acid oxidation.
    Fujinuma S; Nakatsumi H; Shimizu H; Sugiyama S; Harada A; Goya T; Tanaka M; Kohjima M; Takahashi M; Izumi Y; Yagi M; Kang D; Kaneko M; Shigeta M; Bamba T; Ohkawa Y; Nakayama KI
    Cell Rep; 2023 May; 42(5):112530. PubMed ID: 37209098
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PPAR agonists reduce steatosis in oleic acid-overloaded HepaRG cells.
    Rogue A; Anthérieu S; Vluggens A; Umbdenstock T; Claude N; de la Moureyre-Spire C; Weaver RJ; Guillouzo A
    Toxicol Appl Pharmacol; 2014 Apr; 276(1):73-81. PubMed ID: 24534255
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A review of the studies on food-derived factors which regulate energy metabolism via the modulation of lipid-sensing nuclear receptors.
    Goto T
    Biosci Biotechnol Biochem; 2019 Apr; 83(4):579-588. PubMed ID: 30572788
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-Alcoholic Fatty Liver Disease.
    Engin A
    Adv Exp Med Biol; 2017; 960():443-467. PubMed ID: 28585211
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liver Reptin/RUVBL2 controls glucose and lipid metabolism with opposite actions on mTORC1 and mTORC2 signalling.
    Javary J; Allain-Courtois N; Saucisse N; Costet P; Heraud C; Benhamed F; Pierre R; Bure C; Pallares-Lupon N; Do Cruzeiro M; Postic C; Cota D; Dubus P; Rosenbaum J; Benhamouche-Trouillet S
    Gut; 2018 Dec; 67(12):2192-2203. PubMed ID: 29074727
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatic ATF6 Increases Fatty Acid Oxidation to Attenuate Hepatic Steatosis in Mice Through Peroxisome Proliferator-Activated Receptor α.
    Chen X; Zhang F; Gong Q; Cui A; Zhuo S; Hu Z; Han Y; Gao J; Sun Y; Liu Z; Yang Z; Le Y; Gao X; Dong LQ; Gao X; Li Y
    Diabetes; 2016 Jul; 65(7):1904-15. PubMed ID: 27207533
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ETV5 regulates GOAT/ghrelin system in an mTORC1-dependent manner.
    Mao Z; Yang Q; Yin W; Su W; Lin H; Feng M; Pan K; Yin Y; Zhang W
    Mol Cell Endocrinol; 2019 Apr; 485():72-80. PubMed ID: 30735697
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PPARs as Metabolic Regulators in the Liver: Lessons from Liver-Specific PPAR-Null Mice.
    Wang Y; Nakajima T; Gonzalez FJ; Tanaka N
    Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32192216
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of soluble epoxide hydrolase ameliorates hyperhomocysteinemia-induced hepatic steatosis by enhancing β-oxidation of fatty acid in mice.
    Yao L; Cao B; Cheng Q; Cai W; Ye C; Liang J; Liu W; Tan L; Yan M; Li B; He J; Hwang SH; Zhang X; Wang C; Ai D; Hammock BD; Zhu Y
    Am J Physiol Gastrointest Liver Physiol; 2019 Apr; 316(4):G527-G538. PubMed ID: 30789748
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mindin/Spondin 2 inhibits hepatic steatosis, insulin resistance, and obesity via interaction with peroxisome proliferator-activated receptor α in mice.
    Zhu LH; Wang A; Luo P; Wang X; Jiang DS; Deng W; Zhang X; Wang T; Liu Y; Gao L; Zhang S; Zhang X; Zhang J; Li H
    J Hepatol; 2014 May; 60(5):1046-54. PubMed ID: 24445216
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro and in vivo approaches for identifying the role of aryl hydrocarbon receptor in the development of nonalcoholic fatty liver disease.
    Zhu XY; Xia HG; Wang ZH; Li B; Jiang HY; Li DL; Jin R; Jin Y
    Toxicol Lett; 2020 Feb; 319():85-94. PubMed ID: 31730885
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fas cell surface death receptor controls hepatic lipid metabolism by regulating mitochondrial function.
    Item F; Wueest S; Lemos V; Stein S; Lucchini FC; Denzler R; Fisser MC; Challa TD; Pirinen E; Kim Y; Hemmi S; Gulbins E; Gross A; O'Reilly LA; Stoffel M; Auwerx J; Konrad D
    Nat Commun; 2017 Sep; 8(1):480. PubMed ID: 28883393
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dietary phosphate restriction induces hepatic lipid accumulation through dysregulation of cholesterol metabolism in mice.
    Tanaka S; Yamamoto H; Nakahashi O; Kagawa T; Ishiguro M; Masuda M; Kozai M; Ikeda S; Taketani Y; Takeda E
    Nutr Res; 2013 Jul; 33(7):586-93. PubMed ID: 23827134
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The transcription cofactor CRTC1 protects from aberrant hepatic lipid accumulation.
    Kim H
    Sci Rep; 2016 Nov; 6():37280. PubMed ID: 27869139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.